Psoriasis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
- Transparency Market Research
- September 2031
- 0 pages
Psoriasis is an autoimmune disease that produces plaques of thickened, scaling skin which are typically red, itchy, and scaly. They may vary in severity from localized and small to complete body coverage. Skin injury can cause psoriatic skin changes at that spot. Obesity, diabetes, and heart disease are more common in people with psoriasis. Psoriasis can be initiated by certain environmental triggers. The quality of life of patients with psoriasis is often reduced because of the look of their skin. Psoriasis can be seen in people of any age, from small children to adults, most frequently patients are first diagnosed in their initial adult years. Psoriasis is linked to pathogenesis caused by dysregulation of T-cell-dependent immune response, as well as hyperproliferation of keratinocytes, the predominant cell type on the outer layer of skin.
Psoriasis affects skin over the elbows, knees, and scalp and is often itchy. Although any area may be involved, it tends to be more common at sites of friction, scratching, or abrasion. Sometimes pulling off one of these small dry white flakes of skin causes a tiny blood spot on the skin. This is a special diagnostic sign in psoriasis called the Auspitz sign. The introduction of systemic therapies likely to drive the market. However, systemic therapies cannot be provided to various patients such as individuals with liver or kidney disease, pregnant women and nursing mothers. Thus, there is a unmet need existed for the new therapies that can are safe for long-term use and drugs that are in pipeline. According to World Health Organization, the prevalence of psoriasis in countries ranges between 0.09% (2) and 11.4% (3), making psoriasis a serious global problem. Between 1.3% and 34.7% of individuals with psoriasis develop chronic, inflammatory arthritis (psoriatic arthritis) that leads to joint deformations and disability.
The psoriasis market has been segmented by type, by distribution channel and by geography. In terms of type, the psoriasis has been categorized into psoriasis vulgaris, guttate psoriasis (small, drop-like spots), inverse psoriasis (in the folds like of the underarms, navel, groin, and buttocks), and pustular psoriasis (small pus-filled yellowish blisters). Psoriasis vulgaris is the most common type of psoriasis. For the treatment of psoriasis there are six FDA-approved biologics for the treatment of psoriasis belonging to three separate drug classes: Enbrel (etanercept), TNF-? inhibitors including Humira (adalimumab), the IL-17 inhibitors Cosentyx (secukinumab, Novartis), Remicade (infliximab), Taltz (ixekizumab) and the IL-12/23 inhibitor Stelara (ustekinumab). Psoriasis market is also segmented on the basis of distribution channel which comprises, supermarket/ hypermarket, grocery stores, convenience stores, online and others.
Geographically, North America was observed to be the largest psoriasis market due high prevalence of psoriasis. According to American Academy of Dermatology, approximately 7.5 million people in the United States have psoriasis. The most common form of psoriasis, affecting about 80 to 90 percent of psoriasis patients, is plaque psoriasis. It is characterized by patches of raised, reddish skin covered with silvery-white scale. Europe is also significantly affected by psoriasis. According to World Health Organization, Psoriasis was a significant problem for 15% of patients with mild psoriasis, 23% with moderate psoriasis and 51% with severe psoriasis. In addition, 48% of patients reported that their disability due to psoriasis had a modest impact on activities of daily living. China, Japan and India likely to drive the psoriasis market in Asia Pacific
In Latin America, Brazil and Mexico are the regions that have significant potential for growth due to evolving medical structure, and high disposable income.
The major players operating in this market include Johnson & Johnson, AbbVie, AMGen, Novartis International AG, Pfizer Inc., Eli Lilly and Company, Merck & Co., Inc., LEO Pharma A/S, Celgene Corporation, Can-Fite Biopharma Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017